{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "10888620",
  "DateCompleted": {
    "Year": "2000",
    "Month": "08",
    "Day": "10"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "05",
    "Day": "08"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0022-538X",
      "JournalIssue": {
        "Volume": "74",
        "Issue": "15",
        "PubDate": {
          "Year": "2000",
          "Month": "Aug"
        }
      },
      "Title": "Journal of virology",
      "ISOAbbreviation": "J Virol"
    },
    "ArticleTitle": "Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis.",
    "Pagination": {
      "StartPage": "6808",
      "EndPage": "6820",
      "MedlinePgn": "6808-20"
    },
    "Abstract": {
      "AbstractText": [
        "Human cytomegalovirus (CMV) is the leading cause of prenatal viral infection. Affected infants may suffer intrauterine growth retardation and serious neurologic impairment. Analysis of spontaneously aborted conceptuses shows that CMV infects the placenta before the embryo or fetus. In the human hemochorial placenta, maternal blood directly contacts syncytiotrophoblasts that cover chorionic villi and cytotrophoblasts that invade uterine vessels, suggesting possible routes for CMV transmission. To test this hypothesis, we exposed first-trimester chorionic villi and isolated cytotrophoblasts to CMV in vitro. In chorionic villi, syncytiotrophoblasts did not become infected, although clusters of underlying cytotrophoblasts expressed viral proteins. In chorionic villi that were infected with CMV in utero, syncytiotrophoblasts were often spared, whereas cytotrophoblasts and other cells of the villous core expressed viral proteins. Isolated cytotrophoblasts were also permissive for CMV replication in vitro; significantly, infection subsequently impaired the cytotrophoblasts' ability to differentiate and invade. These results suggest two possible routes of CMV transmission to the fetus: (i) across syncytiotrophoblasts with subsequent infection of the underlying cytotrophoblasts and (ii) via invasive cytotrophoblasts within the uterine wall. Furthermore, the observation that CMV infection impairs critical aspects of cytotrophoblast function offers testable hypotheses for explaining the deleterious effects of this virus on pregnancy outcome."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Stomatology, University of California San Francisco, San Francisco, California 94143, USA. sfisher@cgl.ucsf.edu"
          }
        ],
        "LastName": "Fisher",
        "ForeName": "S",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Genbacev",
        "ForeName": "O",
        "Initials": "O"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Maidji",
        "ForeName": "E",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Pereira",
        "ForeName": "L",
        "Initials": "L"
      }
    ],
    "GrantList": [
      {
        "GrantID": "P01 HD030367",
        "Acronym": "HD",
        "Agency": "NICHD NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "AI46657",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "EY10138",
        "Acronym": "EY",
        "Agency": "NEI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R56 AI046657",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 AI046657",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "HD30367",
        "Acronym": "HD",
        "Agency": "NICHD NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, U.S. Gov't, P.H.S."
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Virol",
    "NlmUniqueID": "0113724",
    "ISSNLinking": "0022-538X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "HLA Antigens"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "HLA-G Antigens"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Histocompatibility Antigens Class I"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Integrin alpha1beta1"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Integrins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Viral Proteins"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Cells, Cultured"
    },
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "Chorionic Villi"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Culture Techniques"
    },
    {
      "QualifierName": [
        "genetics",
        "pathogenicity",
        "physiology"
      ],
      "DescriptorName": "Cytomegalovirus"
    },
    {
      "QualifierName": [
        "pathology",
        "transmission",
        "virology"
      ],
      "DescriptorName": "Cytomegalovirus Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Down-Regulation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "HLA Antigens"
    },
    {
      "QualifierName": [],
      "DescriptorName": "HLA-G Antigens"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Histocompatibility Antigens Class I"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infectious Disease Transmission, Vertical"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Integrin alpha1beta1"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Integrins"
    },
    {
      "QualifierName": [
        "cytology",
        "virology"
      ],
      "DescriptorName": "Placenta"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pregnancy"
    },
    {
      "QualifierName": [
        "pathology",
        "virology"
      ],
      "DescriptorName": "Pregnancy Complications, Infectious"
    },
    {
      "QualifierName": [
        "metabolism",
        "virology"
      ],
      "DescriptorName": "Trophoblasts"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Viral Proteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Virion"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Virus Replication"
    }
  ]
}